Detalles de la búsqueda
1.
High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient.
Cancer Immunol Immunother
; 70(3): 831-842, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33140187
2.
Altered Metabolism in Glioblastoma: Myeloid-Derived Suppressor Cell (MDSC) Fitness and Tumor-Infiltrating Lymphocyte (TIL) Dysfunction.
Int J Mol Sci
; 22(9)2021 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33923299
3.
Altered function of the glutamate-aspartate transporter GLAST, a potential therapeutic target in glioblastoma.
Int J Cancer
; 144(10): 2539-2554, 2019 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30418668
4.
ABCC3 Expressed by CD56dim CD16+ NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy.
Int J Mol Sci
; 20(23)2019 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31771235
5.
Revisiting the Immunological Aspects of Temozolomide Considering the Genetic Landscape and the Immune Microenvironment Composition of Glioblastoma.
Front Oncol
; 11: 747690, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34646780
6.
Deciphering the Labyrinthine System of the Immune Microenvironment in Recurrent Glioblastoma: Recent Original Advances and Lessons from Clinical Immunotherapeutic Approaches.
Cancers (Basel)
; 13(24)2021 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34944776
7.
B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres.
EBioMedicine
; 47: 33-43, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31466914
8.
Expansion of effector and memory T cells is associated with increased survival in recurrent glioblastomas treated with dendritic cell immunotherapy.
Neurooncol Adv
; 1(1): vdz022, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-32642658
9.
Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy.
Sci Transl Med
; 10(430)2018 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29491184
10.
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastoma.
Oncotarget
; 7(49): 80820-80841, 2016 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27821809
11.
The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma.
Oncoimmunology
; 5(5): e1108513, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27467914
12.
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype.
PLoS One
; 9(4): e94568, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24736663
13.
TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype.
Biomed Res Int
; 2013: 740187, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23841091
14.
Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain.
FEBS Lett
; 586(16): 2366-74, 2012 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-22677171
15.
Constitutive autotaxin transcription by Nmyc-amplified and non-amplified neuroblastoma cells is regulated by a novel AP-1 and SP-mediated mechanism and abrogated by curcumin.
FEBS Lett
; 586(20): 3681-91, 2012 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-22975311
16.
Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells.
FEBS Lett
; 585(20): 3328-36, 2011 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21963718
Resultados
1 -
16
de 16
1
Próxima >
>>